(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
The development of new CNS drugs is notoriously difficult. Drugs must reach CNS target sites for action and these sites are protected by a number of barriers, the most important being the blood -brain barrier (BBB). Many factors are therefore critical to consider for CNS drug delivery, e.g. active/passive transport across the BBB, intra-brain distribution, and central/systemic pharmacokinetics, to name a few. Neurological disease and trauma conditions add further complexity because CNS barriers, drug distribution and pharmacokinetics are dynamic and often changed by disease/trauma. Knowledge of all these factors and their interplay in different conditions is of utmost importance for proper CNS drug development and disease treatment. In recent years much information has become available for a better understanding of the many factors important for CNS drug delivery and how they interact to affect drug action. This book describes small and large drug delivery to the brain with an emphasis on the physiology of the BBB and the principles and concepts for drug delivery across the BBB and distribution within the brain. It contains methods descriptions for studying drug delivery, routes and approaches of administering drugs into the brain, the influence of disease, and drug industry perspectives. Therewith, it contributes to an in-depth understanding of the interplay between brain (patho)-physiology and drug characteristics. Furthermore, the content is designed to be both cutting-edge and educational, so that the book can be used in high-level training of academic and industry scientists with full references to original publications.
Contents:
I. PHYSIOLOGY AND BASIC PRINCIPLES FOR DRUG HANDLING BY THE BRAIN
1. Anatomy and physiology of the blood-brain barriers
N Joan Abbott
2. Recent Progress in Blood-Brain Barrier and Blood-CSF Barrier Transport Research: Pharmaceutical Relevance for Drug Delivery to the Brain
Masanori Tachikawa, Yasuo Uchida, Sumio Ohtsuki and Tetsuya Terasaki
3. Blood-Brain Barrier (BBB) Pharmacoproteomics: A New Research Field Opened up by Quantitative Targeted Absolute Proteomics (QTAP)
Yasuo Uchida, Masanori Tachikawa, Sumio Ohtsuki And Tetsuya Terasaki
4. Drug Metabolism at the Blood-Brain and Blood-CSF Barriers
Xavier Decleves, Nathalie Strazielle, Jean-Michel Scherrmann and Jean-Francois Ghersi-Egea
II. PHARMACOKINETIC CONCEPTS AND METHODS FOR STUDYING DRUG DELIVERY ACROSS THE BLOOD-BRAIN BARRIER
5. Pharmacokinetic Concepts in Brain Drug Delivery
Margareta Hammarlund-Udenaes
6. In vitro models of blood-brain barriers
N Joan Abbott, Diana EM Dolman, Siti R Yusof and Andreas Reichel
7. In situ and in vivo animal models
Quentin Smith and Ramakrishna Samala
8. Principles of PET and its Role in Understanding Drug Delivery to the Brain
Stina Syvanen and Roger N. Gunn
9. PKPD Aspects of Brain Drug Delivery in a Translational Perspective
Elizabeth C.M. de Lange
III. INDUSTRIAL APPROACHES FOR INVESTIGATION OF POTENTIAL CENTRAL NERVOUS SYSTEM DRUGS
10. Drug Discovery Methods for Studying Brain Drug Delivery and Distribution
Irena Loryan and Margareta Hammarlund-Udenaes
11. Prediction of Drug Exposure in the Brain from the Chemical Structure
Markus Friden
12. Integrated Approach to Optimizing CNS Penetration in Drug Discovery: From the old to the new Paradigm and Assessment of Drug-Transporter Interactions
Andreas Reichel
13. Pharmacoeconomic Considerations in CNS Drug Development
David Gray
IV. STRATEGIES FOR IMPROVED CENTRAL NERVOUS SYSTEM DRUG DELIVERY
14. Intranasal Drug Delivery to the Brain
Jeffrey J. Lochhead and Robert G. Thorne
15. Blood-To-Brain Drug Delivery using Nanocarriers
Pieter J. Gaillard, Corine C. Visser, Marco de Boer, Chantal C.M. Appeldoorn and Jaap Rip
16. Development of new Protein Vectors for the Physiologic Delivery of Large Therapeutic Compounds to the CNS
Reinhard Gabathuler
17. CNS Gene Therapy Utilizing Intravenously Administered Viral Vectors
Adam K. Bevan and Brian K. Kaspar
18. Neurosurgical Approaches: Drug Infusion Directly into the Parenchyma or Cerebrospinal Fluid
Krystof Bankiewicz
19. Osmotic Opening of the BBB for Drug Treatment of Brain Tumors (Focus on Methodological Issues)
David Fortin
20. Emerging Engineering Technologies for Opening the BBB
Elisa E. Konofagou
V. BRAIN DRUG DELIVERY IN DISEASE CONDITIONS
21. Disease Influence on BBB Transport in Inflammatory Disorders
Geert Schenk, Gijs Kooij, Arie Reijerkerk and Helga de Vries
22. Disease Influence on BBB Transport in Neurodegenerative Disorders
Elizabeth C.M. de Lange
23. Drug Delivery in the Context of Stroke and Brain Trauma
Richard F. Keep, Jianming Xiang, Ningna Zhou and Anuska V. Andjelkovic
24. Which Drug or Drug Delivery Method can change Clinical Practice for Brain Tumor Therapy?
Tali Siegal
Appending - Primer on Central Nervous System Structure / Function and the Vasculature, Ventricular System and Fluids of the Brain. Robert Thorne
PRODUCT DETAILS
Publisher: Springer (Springer-Verlag New York Inc.)
Publication date: December, 2013
Pages: 530
Weight: 652g
Availability: Not available (reason unspecified)
Subcategories: General Issues, Neurology, Pharmacology
Publisher recommends
From the same series